Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
This study is ongoing, but not recruiting participants.
Study NCT00187057 Information provided by St. Jude Children's Research Hospital
First Received on September 12, 2005. Last Updated on July 24, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ataxia-Telangiectasia
Additional conditions recognized in this trial
Ataxia
Ataxia Telangiectasia
Telangiectasis
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebellar Ataxia
Cerebellar Diseases
DNA Repair-Deficiency Disorders
Dyskinesias
Genetic Diseases, Inborn
Immune System Diseases
Immunologic Deficiency Syndromes
Metabolic Diseases
Nervous System Diseases
Neurocutaneous Syndromes
Neurologic Manifestations
Signs and Symptoms
Spinocerebellar Ataxias
Vascular Diseases
Interventions listed in this trial
dexamethasone, procarbazine
Additional drug interventions recognized in this trial
6-Mercaptopurine
Asparaginase
BB 1101
Cyclophosphamide
Cytarabine
Daunorubicin
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Doxorubicin
Etoposide
Methotrexate
Prednisone
Procarbazine
Vinblastine
Vincristine
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Alkylating Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antiemetics
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Antiviral Agents
Autonomic Agents
Central Nervous System Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Reproductive Control Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
St. Jude Children's Research Hospital
Children's Hospital of Philadelphia
National Cancer Institute (NCI)
Back to top of Main Content
